Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$1.0 million.

  • Journey Medical's Change in Inventory fell 14921.47% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30000.0, marking a year-over-year decrease of 9607.33%. This contributed to the annual value of $4.2 million for FY2024, which is 20688.08% up from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Change in Inventory is -$1.0 million, which was down 14921.47% from $356000.0 recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Change in Inventory ranged from a high of $12.0 million in Q2 2021 and a low of -$2.7 million during Q3 2021
  • Its 5-year average for Change in Inventory is $230157.9, with a median of -$823000.0 in 2022.
  • In the last 5 years, Journey Medical's Change in Inventory plummeted by 122380.95% in 2023 and then soared by 42310.51% in 2024.
  • Journey Medical's Change in Inventory (Quarter) stood at -$1.8 million in 2021, then skyrocketed by 38.87% to -$1.1 million in 2022, then grew by 23.62% to -$818000.0 in 2023, then surged by 423.11% to $2.6 million in 2024, then tumbled by 139.12% to -$1.0 million in 2025.
  • Its last three reported values are -$1.0 million in Q3 2025, $356000.0 for Q2 2025, and -$1.9 million during Q1 2025.